How do I determine the appropriate intravenous iron dose based on patient weight and iron studies (transferrin saturation and ferritin) for a dialysis patient?

IV Iron Dosing for Dialysis Patients

For hemodialysis patients, administer 100-200 mg of IV iron monthly when ferritin ≤200 ng/mL or TSAT ≤20%, with the goal of maintaining ferritin 200-800 ng/mL and TSAT 20-40%. 1

Initiation Criteria

Start IV iron therapy when:

• Ferritin ≤200 ng/mL, OR 2
• TSAT ≤20% (even if ferritin is between 200-800 ng/mL, indicating functional iron deficiency) 1, 2

The TSAT <20% threshold has high sensitivity for diagnosing both absolute and functional iron deficiency in dialysis patients. 3

Dosing Strategy

Two evidence-based approaches exist:

High-Dose Proactive Regimen (Preferred)

• 400 mg monthly (typically divided as 100 mg per dialysis session weekly) 4
• Superior outcomes: 15% reduction in cardiovascular events and death (HR 0.85,95% CI 0.73-1.00, P=0.04 for superiority) 4
• Reduces ESA requirements by approximately 9,000 IU monthly 4
• Mean monthly dose achieved: 264 mg 4

Moderate-Dose Maintenance Regimen

• 200 mg monthly reduces ESA dose by 26% compared to 100 mg monthly 5
• 100 mg monthly results in 30% absolute iron deficiency rate vs. 10.5% with 200 mg 5
• The 200 mg regimen has higher withholding rates (64% vs. 25%) but better iron repletion 5

Stopping Criteria

Hold IV iron when:

• Ferritin ≥800 ng/mL AND TSAT ≥20%, OR 1, 6
• TSAT ≥40% (regardless of ferritin level) 1, 6

Never exceed ferritin >800 ng/mL in routine practice, as this approaches iron overload territory. 6

Target Parameters

Maintain these levels:

• Ferritin: 200-800 ng/mL 1, 2
• TSAT: 20-40% 1
• Hemoglobin: 10-12 g/dL 5

The KDIGO guidelines specifically recommend maintaining ferritin >200 ng/mL and TSAT >20% to minimize ESA requirements in hemodialysis patients. 2

Monitoring Schedule

Check iron parameters:

• Every 3 months during stable maintenance therapy 2
• 4-8 weeks after any dose adjustment 3
• Critical timing consideration: Ferritin remains spuriously elevated for 2-3 weeks after 100-200 mg IV iron doses 7
• TSAT returns to baseline within 4 days 7

Avoid checking ferritin within 4 weeks of IV iron administration, as circulating iron interferes with the assay leading to falsely elevated results. 3

Formulation-Specific Dosing

Iron dextran, ferric carboxymaltose, or ferumoxytol:

• Can be given as total dose infusion up to 1000-1500 mg 3
• Ferric derisomaltose (FDI) is FDA-approved for doses up to 20 mg/kg, not exceeding 1500 mg 3
• Dilute in 100 mL normal saline 3

Iron sucrose:

• Typically given as 100 mg per dialysis session 4, 8
• Maximum single dose 200-300 mg 8

Common Pitfalls

Functional vs. Absolute Iron Deficiency:

• Functional deficiency: TSAT ≤20% with ferritin 100-800 ng/mL (hepcidin-mediated iron sequestration) 2
• Absolute deficiency: Ferritin <100 ng/mL 2
• Both require IV iron in dialysis patients 2

Inflammation confounds ferritin interpretation:

• Ferritin is an acute phase reactant and may be elevated despite true iron deficiency 3
• In discordant cases (high ferritin, low TSAT), the TSAT is more reliable for guiding therapy 3
• Consider reticulocyte hemoglobin content (CHr <29 pg indicates iron deficiency) if available 9

Dosing frequency matters:

• Monthly 200 mg is more effective than 100 mg for reducing ESA requirements 5
• Proactive high-dose (400 mg monthly) reduces cardiovascular events compared to reactive low-dose (145 mg monthly) 4

Safety Considerations

Infection risk:

• No increased infection rate with high-dose vs. low-dose IV iron regimens 4
• Current guidelines do not increase bacterial infection risk 2

Test dosing:

• Consider 25 mg test dose for iron dextran formulations 2
• Newer formulations (ferric carboxymaltose, ferumoxytol, ferric derisomaltose) typically do not require test dosing 3